These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 12530030

  • 1. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Harada K, Supriatno, Yoshida H, Sato M.
    Anticancer Res; 2002; 22(5):2985-9. PubMed ID: 12530030
    [Abstract] [Full Text] [Related]

  • 2. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M.
    Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M.
    Clin Cancer Res; 2005 Jan 01; 11(1):259-66. PubMed ID: 15671554
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Anticancer Res; 2006 Oct 01; 26(2B):1615-9. PubMed ID: 16619581
    [Abstract] [Full Text] [Related]

  • 7. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V, Ferrandina G, Pucci B, Fanfani F, Lovergine S, Palazzo J, Zannoni G, Mancuso S, Scambia G, Giordano A.
    Clin Cancer Res; 2000 Dec 01; 6(12):4816-22. PubMed ID: 11156240
    [Abstract] [Full Text] [Related]

  • 8. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M.
    Oncol Rep; 2003 Dec 01; 10(2):321-5. PubMed ID: 12579266
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H.
    J Surg Oncol; 2002 Dec 01; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. p27KIP1-expression in human renal cell cancers: implications for clinical outcome.
    Anastasiadis AG, Calvo-Sanchez D, Franke KH, Ebert T, Heydthausen M, Schulz WA, Burchardt M, Gerharz CD.
    Anticancer Res; 2003 Dec 01; 23(1A):217-21. PubMed ID: 12680216
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ, Montironi R.
    Eur Urol; 2004 May 01; 45(5):606-12. PubMed ID: 15082203
    [Abstract] [Full Text] [Related]

  • 13. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
    Migita T, Oda Y, Naito S, Tsuneyoshi M.
    Cancer; 2002 Feb 15; 94(4):973-9. PubMed ID: 11920465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
    Sgambato A, Migaldi M, Faraglia B, Garagnani L, Romano G, De Gaetani C, Ferrari P, Capelli G, Trentini GP, Cittadini A.
    Cancer Res; 1999 Jul 01; 59(13):3245-50. PubMed ID: 10397272
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R.
    Am J Clin Pathol; 2004 Sep 01; 122(3):444-52. PubMed ID: 15362377
    [Abstract] [Full Text] [Related]

  • 17. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J, Adamopoulos G.
    Anticancer Res; 2001 Sep 01; 21(1B):521-8. PubMed ID: 11299798
    [Abstract] [Full Text] [Related]

  • 18. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S, Tamiya T, Ono Y, Abe T, Matsumoto K, Furuta T, Ohmoto T.
    Clin Cancer Res; 1999 Mar 01; 5(3):551-7. PubMed ID: 10100706
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA, Nemes Z, Márton IJ.
    J Oral Pathol Med; 2005 May 01; 34(5):274-9. PubMed ID: 15817070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.